Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 060012/0292 | |
| Pages: | 11 |
| | Recorded: | 05/25/2022 | | |
| Attorney Dkt #: | PRD4135USNP1 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17702282
|
Filing Dt:
|
03/23/2022
|
|
Publication #:
|
|
Pub Dt:
|
10/06/2022
| | | | |
|
Title:
|
TRISPECIFIC ANTIBODY TARGETING CD79b, CD20, AND CD3
|
|
|
Assignee
|
|
|
|
|
| 920 US ROUTE 202 |
| P.O. BOX 300 |
| RARITAN, NEW JERSEY 08869 |
|
|
Correspondence name and address
|
| |
JOSEPH F. SHIRTZ
|
| |
ONE JOHNSON & JOHNSON PLAZA
|
| |
NEW BRUNSWICK, NJ 08933
|
Search Results as of:
06/14/2024 04:28 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
